Peri-implantitis. Other endosseous dental implant failure
Conditions
Interventions
Intervention 1: Intervention group: After local anesthesia (Xylocaine Dental (lidocaine HCl)) and isolation and drying of metronidazole (AEROTEX manufacture by Sina daru pharmaceutical company, Iran)
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Inclusion criteria
Inclusion criteria: Presence of pre-implant disease No history of pre-implant surgery treatment pocket depth>6 mm Positive bleeding on probing No antibiotics and mouthwash and periodontal treatment in the last 6 weeks Absence of underlying disease PFM Base Restoration
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding Allergy to metronidazole Chronic drug use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence or absence of plaque on tooth and implant surfaces (mesial, distal, buccal and lingual surfaces). Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;The distance between the gingival margin and the depth of the envelope is in millimeters. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;Presence or absence of bleeding after probing. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination.;The distance between the acrylic stent and the depth of the pocket. Timepoint: 1 and 3 months after the intervention. Method of measurement: Clinical dental examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMorteza Nasirzadeh
Tabriz University of Medical Sciences
Outcome results
None listed